Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...
The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...
Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
Early trial outcomes report progression-free survival and response charges for ateganosine, spevatamig, Annamycin and pumitamig; research are at present enrolling.CURE’s Scientific Trial Nook...
The FDA granted breakthrough remedy designation to R-DXd for adults with CDH6-expressing platinum-resistant ovarian, peritoneal or fallopian tube cancers.Raludotatug deruxtecan (R-DXd) has been...
For males with prostate most cancers, radical prostatectomy, or surgical removing of the prostate, isn’t assured to be healing, as one knowledgeable defined.Amongst...
Dr. Joshua Ok. Sabari, a thoracic medical oncologist at NYU Langone Well being’s Perlmutter Most cancers Heart and editor-in-chief of CURE, sat down...
